CTOs on the Move

Acer Therapeutics

www.acertx.com

 
Acer Therapeutics is a biotech company, headquartered in Cambridge, MA, that develops repurposed and reformulated medicines for the treatment of ultra-orphan diseases with significant unmet medical needs. Acer`s lead candidate, EDVISO™ (celiprolol), is the first pharmaceutical therapy seeking approval for patients with vascular-type Ehlers-Danlos syndrome (vEDS). Ehlers-Danlos Syndrome is a group of hereditary disorders of connective tissue with no ethnic predisposition. vEDS is a subtype characterized by severe arterial dissections, ruptures and early death. Complications are rare in childhood, but affect 25% of patients before the age of 20, and 80% by the age of 40. Median age of death ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.acertx.com
  • One Gateway Center, Suite 351 300 Washington Street
    Newton, MA USA 02458
  • Phone: 844.902.6100

Executives

Name Title Contact Details

Funding

Acer Therapeutics raised $48M on 03/07/2022

Similar Companies

Alfagene Bioscience

Alfagene Bioscience is a Fords, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aphria Incorporated

Headquartered in Leamington, Ontario – the greenhouse capital of Canada – Aphria has been setting the standard for safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible.

Zymes

Zymes is a Hasbrouck Heights, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Meridian Behavioral Healthcare,

Serving North Central Florida, covering a geographic area of almost 7,500 square miles that is largely rural and sparsely populated, serving the following 12 counties: Alachua, Baker, Bradford, Columbia, Dixie, Gilchrist, Hamilton, Lafayette, Levy, Put...

Sandoz

Sandoz, a Division of the Novartis group, is a global leader in the field of generic pharmaceuticals, offering a wide array of high-quality, affordable products that are no longer protected by patents.